Diabetech - Diabetes Tech, Research, News

Trio version 1.0 is here! This is the largest system update to date for the open-source automated insulin delivery (AID) system. The latest release adds new pump and CGM integrations, a redesigned app, customizable alerts, glucose forecasts, and new features like Quick Picks. This episode explores how Trio’s open-source approach differs from commercial AID systems and how users can customize the system around their diabetes management needs. Contributors Teresa Hastings and Magnus Wrights also share how they use Trio, including approaches that can reduce the need for manual boluses and carbohydrate entries. The conversation also covers Trio’s algorithm, dynamic insulin sensitivity, Apple Watch and Garmin integration, upcoming pump integrations, and what could be next for open-source AID.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Resources: Triodocs Website  | Loop and Learn  | Hackathon fundraising    Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice. Always consult with your doctor before making changes to your health care. DIY apps are experimental and not approved by the FDA or regulatory authorities at the time of this video. You take full responsibility for building and using DIY apps and you do so at your own risk. Results will vary.   *Omnipod (today's sponsor): 30-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Your pump and CGM lose connection in the pool, and it comes down to centimeters. I sat down with Dr. Michael Hughes, an endocrinologist at Emory University, to break down his research on swimming with automated insulin delivery (AID). His team found the connection held at 100% at 10 cm, dropped to about half at 13 cm, and hit 0% by 17 cm, so where you place your pod and CGM matters a lot for swimming with type 1 diabetes. We also cover what limited mode does when your devices disconnect, and why starting glucose and insulin on board mattered more than connectivity for avoiding lows.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.     

Are you getting the most out of your automated insulin delivery system, or are you still managing it like a traditional insulin pump? Gary Scheiner, CDCES, and I break down 10 ways to optimize your AID system, from fine-tuning pump settings and knowing when to bolus to treating lows and timing insulin more effectively. We also cover how to trust the algorithm, use advanced pump features for exercise and meals, rotate infusion sites, and keep your CGM data reliable.   Learn about Omnipod 5 (today's sponsor)*   Learn about the Eversense 365 CGM   Integrated Diabetes - work with Gary's team   Optimizing Diabetes Tech Playlist   Listen to Diabetes Advocates (New Podcast): Apple | Spotify | YouTube   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Abbott's VP of Technical Operations and Senior Medical Director break down the new Libre Duo sensor, the first continuous glucose ketone monitor. We discuss the growing need for more ketone data, how ketone alerts will appear in the existing Libre app, and why the company designed the experience to minimize alert and information fatigue. The conversation also covers Libre Duo’s compatibility with leading automated insulin delivery systems.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Listen to Diabetes Advocates: YouTube | Apple | Spotify   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.     

Eledon's CEO, Dr. David-Alexandre Gros, breaks down Tegoprubart, the company’s targeted immunosuppressant being studied alongside islet cell transplants for type 1 diabetes. The conversation covers the promising results seen so far, including insulin independence and improved A1C levels among trial participants, and why Tego could offer a different approach to protecting transplanted cells. The episode also explores what the future of type 1 diabetes treatment could look like as transplantation, stem-cell-derived islets, and new immunosuppressive therapies continue to advance.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (sponsor)*   Watch Next: Type 1 Diabetes Cure Research    Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Ever wonder what insulin pump options exist outside the U.S.? Dr. Inge Van Boxelaer, a Belgian endocrinologist and founder of Diabetotech, joins us on the podcast and breaks down the European AID system landscape. We cover how MiniMed, Tandem, and Omnipod are performing across European markets, plus a deep dive into European systems like the Kaleido, mylife YpsoPump (with CamAPS FX and the upcoming Liberty algorithm), the Diabeloop-powered systems, and the Medtrum Touchcare. The conversation also explores how reimbursement and regulatory approval vary wildly by country, and where the market is headed next with patch pumps, phone-controlled systems, and fully closed-loop technology.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Check out Diabetotech   Podcast: Medtrum User Interview, CamAPS FX Explained   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

Part two of this series continues the conversation about what a cure for type 1 diabetes could actually look like, from cell replacement and immune therapies to insulin innovation and advanced diabetes technology. The discussion explores islet cell transplants, stem cell-derived beta cells, immune suppression, gene-edited cells, and the challenges of making these approaches safer and more widely available. The expert panel also break down why even the most advanced technology today still falls short of a true cure. A major focus is accessibility, including who could benefit from these therapies, how much they might cost, and the infrastructure needed to deliver them to millions of people with type 1 diabetes. The experts discuss their vision for the future of cure research and how far off it could be.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Could Prevention be the Cure for Type 1 Diabetes?   The Cure Post-Show Reaction   Diabetech Feedback Survey   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

In this episode, I sit down with leading type 1 diabetes researchers and clinicians to break down the science behind prevention, delaying disease progression, and replacing insulin-producing beta cells. We explore promising therapies like teplizumab, ATG, and verapamil, along with the challenges of immunotherapy, beta cell replacement, and making these treatments accessible to more people. This conversation also tackles why we’ve been hearing “a cure in 5 to 10 years” for so long, what researchers have learned about the root causes of type 1 diabetes, and why there’s more progress happening now than ever before.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Inside the Vertex Participant Who's Cured of Type 1 Diabetes - Patti Columbe She's "Cured" of Type 1 Diabetes - Life 6 Months Later - Katie Beth    The Cure Post-Show Reaction   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

When your CGM fails, your pump dies, or you're caught in a situation without access to your tech, do you know what to do? Gary Scheiner and I break down the "back to basics" skills every T1D needs to know from manual carb counting to calculating correction doses without a pump, to safely transitioning from a pump to MDI (and back again). We also cover what belongs in your diabetes emergency go-bag and how to best manage your care in the event of a natural disaster.   Learn about the Eversense 365 CGM   Learn about Omnipod 5 (today's sponsor)*   Integrated Diabetes - work with Gary and his team   Join the T1D Exchange Registry (affiliate)   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   Emergency Resources:  FRIO (10% off JUSTIN10) Your'e Just My Type Grown Up T1D Breakthrough T1D   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

A cure for type 1 diabetes has always felt like a distant idea, but for Patti Columbe, it's now her reality. After living with type 1 for 40 years, Patti shares her journey as a participant of the Vertex VX-880 clinical trial, where a lab-grown islet cell transplant has left her insulin-free and functionally cured. She opens up about the emotional challenges of adapting to life without diabetes and why she believes hope is finally becoming reality for the T1D community. This conversation also explores the future of stem cell therapies, immunosuppression, and what it could take to make these treatments available to more people.   Learn about Omnipod 5 (sponsor)*   Learn about the Eversense 365 CGM   Join: Diabetech Newsletter (free) | Diabetech All Access   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Discord   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.